These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


100 related items for PubMed ID: 17267315

  • 1. Immunohistochemical analysis of pro-apoptotic PUMA protein and mutational analysis of PUMA gene in gastric carcinomas.
    Yoo NJ, Lee JW, Jeong EG, Lee SH.
    Dig Liver Dis; 2007 Mar; 39(3):222-7. PubMed ID: 17267315
    [Abstract] [Full Text] [Related]

  • 2. Mutational and expressional analysis of BNIP3, a pro-apoptotic Bcl-2 member, in gastric carcinomas.
    Lee SH, Jeong EG, Yoo NJ, Lee SH.
    APMIS; 2007 Nov; 115(11):1274-80. PubMed ID: 18092960
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical analysis of phospho-BAD protein and mutational analysis of BAD gene in gastric carcinomas.
    Jeong EG, Lee SH, Kim SS, Ahn CH, Yoo NJ, Lee SH.
    APMIS; 2007 Aug; 115(8):976-81. PubMed ID: 17696955
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical and mutational analysis of FLASH in gastric carcinomas.
    Jeong EG, Lee SH, Lee HW, Soung YH, Yoo NJ, Lee SH.
    APMIS; 2007 Aug; 115(8):900-5. PubMed ID: 17696945
    [Abstract] [Full Text] [Related]

  • 5. Pro-apoptotic PUMA and anti-apoptotic phospho-BAD are highly expressed in colorectal carcinomas.
    Kim MR, Jeong EG, Chae B, Lee JW, Soung YH, Nam SW, Lee JY, Yoo NJ, Lee SH.
    Dig Dis Sci; 2007 Oct; 52(10):2751-6. PubMed ID: 17393317
    [Abstract] [Full Text] [Related]

  • 6. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
    Dvory-Sobol H, Sagiv E, Liberman E, Kazanov D, Arber N.
    Cancer; 2007 Jan 15; 109(2):188-97. PubMed ID: 17149756
    [Abstract] [Full Text] [Related]

  • 7. Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas.
    Lee JW, Jeong EG, Soung YH, Nam SW, Lee JY, Yoo NJ, Lee SH.
    Pathology; 2006 Aug 15; 38(4):312-5. PubMed ID: 16916719
    [Abstract] [Full Text] [Related]

  • 8. Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway.
    Concannon CG, Koehler BF, Reimertz C, Murphy BM, Bonner C, Thurow N, Ward MW, Villunger A, Strasser A, Kögel D, Prehn JH.
    Oncogene; 2007 Mar 15; 26(12):1681-92. PubMed ID: 16983338
    [Abstract] [Full Text] [Related]

  • 9. Expressional analysis of anti-apoptotic phospho-BAD protein and mutational analysis of pro-apoptotic BAD gene in hepatocellular carcinomas.
    Yoo NJ, Lee JW, Jeong EG, Soung YH, Nam SW, Lee JY, Lee SH.
    Dig Liver Dis; 2006 Sep 15; 38(9):683-7. PubMed ID: 16807152
    [Abstract] [Full Text] [Related]

  • 10. Sp1 is involved in H2O2-induced PUMA gene expression and apoptosis in colorectal cancer cells.
    Wang X, Wang J, Lin S, Geng Y, Wang J, Jiang B.
    J Exp Clin Cancer Res; 2008 Sep 24; 27(1):44. PubMed ID: 18811981
    [Abstract] [Full Text] [Related]

  • 11. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Sep 24; 117(1):45-54. PubMed ID: 18791823
    [Abstract] [Full Text] [Related]

  • 12. Inactivating mutation of the pro-apoptotic gene BID in gastric cancer.
    Lee JH, Soung YH, Lee JW, Park WS, Kim SY, Cho YG, Kim CJ, Seo SH, Kim HS, Nam SW, Yoo NJ, Lee SH, Lee JY.
    J Pathol; 2004 Apr 24; 202(4):439-45. PubMed ID: 15095271
    [Abstract] [Full Text] [Related]

  • 13. mRNA and protein expression of PUMA in sporadic colorectal cancer.
    Jansson A, Arbman G, Sun XF.
    Oncol Rep; 2004 Dec 24; 12(6):1245-9. PubMed ID: 15547745
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical and mutational analysis of apoptosis-inducing factor (AIF) in colorectal carcinomas.
    Jeong EG, Lee JW, Soung YH, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH.
    APMIS; 2006 Dec 24; 114(12):867-73. PubMed ID: 17207087
    [Abstract] [Full Text] [Related]

  • 15. PUMA expression is significantly reduced in human cutaneous melanomas.
    Karst AM, Dai DL, Martinka M, Li G.
    Oncogene; 2005 Feb 03; 24(6):1111-6. PubMed ID: 15690057
    [Abstract] [Full Text] [Related]

  • 16. p53-insensitive PUMA down-regulation is essential in the early phase of liver regeneration after partial hepatectomy in mice.
    Chen S, Zheng J, Hao Q, Yang S, Wang J, Chen H, Chen L, Zhou Y, Yu C, Jiao B, Cai Z.
    J Hepatol; 2010 Jun 03; 52(6):864-71. PubMed ID: 20413175
    [Abstract] [Full Text] [Related]

  • 17. Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas.
    Soung YH, Lee JW, Kim SY, Park WS, Nam SW, Lee JY, Yoo NJ, Lee SH.
    APMIS; 2006 Apr 03; 114(4):292-7. PubMed ID: 16689829
    [Abstract] [Full Text] [Related]

  • 18. Mathematical model of a network of interaction between p53 and Bcl-2 during genotoxic-induced apoptosis.
    Dogu Y, Díaz J.
    Biophys Chem; 2009 Jul 03; 143(1-2):44-54. PubMed ID: 19395147
    [Abstract] [Full Text] [Related]

  • 19. Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells.
    Liu HF, Hsiao PW, Chao JI.
    Chem Biol Interact; 2008 Oct 22; 176(1):48-57. PubMed ID: 18760266
    [Abstract] [Full Text] [Related]

  • 20. Expressional and mutational analysis of pro-apoptotic Bcl-2 member PUMA in hepatocellular carcinomas.
    Ahn CH, Jeong EG, Kim SS, Lee JW, Lee SH, Kim SH, Kim MS, Yoo NJ, Lee SH.
    Dig Dis Sci; 2008 May 22; 53(5):1395-9. PubMed ID: 17934815
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.